P34 Effects of nateglinide and metformin on glycated insulin secretion in type 2 diabetes

被引:0
|
作者
Crawford, M. A. [1 ]
O'Harte, F. P. M. [1 ]
Cuthbertson, J. [2 ]
Bell, P. R. [2 ]
Flatt, P. R. [1 ]
McKillop, A. M. [1 ]
机构
[1] Univ Ulster, Biomed Sci Res Inst, Coleraine BT52 1SA, Londonderry, North Ireland
[2] Royal Victoria Hosp, Belfast BT12 6BA, Antrim, North Ireland
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:S496 / S496
页数:1
相关论文
共 50 条
  • [1] Effects of nateglinide on the secretion of glycated insulin and glucose tolerance in type 2 diabetes
    Lindsay, JR
    McKillop, AM
    Mooney, MH
    O'Harte, FPM
    Flatt, PR
    Bell, PM
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2003, 61 (03) : 167 - 173
  • [2] Effects of nateglinide in combination with basal insulin glargine with metformin and/or thiazolidinedione in type 2 diabetes patients
    Israel, Marc K.
    Dabrowski, Irena
    Purkayastha, Das
    DIABETES, 2008, 57 : A572 - A572
  • [3] Nateglinide combination therapy with basal insulin and metformin in patients with Type 2 diabetes
    Juurinen, L.
    Tiikkainen, M.
    Saltevo, J.
    Nikkila, K.
    Lanki, H.
    Leppavuori, E.
    Kock, T.
    Teikari-Myyra, T.
    Kauppinen-Makelin, R.
    Kotronen, A.
    Yki-Jarvinen, H.
    DIABETIC MEDICINE, 2009, 26 (04) : 409 - 415
  • [4] Synergistic effects of nateglinide and meal administration on insulin secretion in patients with type 2 diabetes mellitus
    Keilson, L
    Mather, S
    Walter, YH
    Subramanian, S
    McLeod, JF
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (03): : 1081 - 1086
  • [5] Favorable effects of early insulin secretion by nateglinide on postprandial hyperlipidemia in patients with type 2 diabetes
    Ai, M
    Tanaka, A
    Ogita, K
    Shimokado, K
    DIABETES CARE, 2006, 29 (05) : 1180 - 1180
  • [6] Effects of the new oral hypoglycaemic agent nateglinide on insulin secretion in Type 2 diabetes mellitus
    Whitelaw, DC
    Clark, PM
    Smith, JM
    Nattrass, M
    DIABETIC MEDICINE, 2000, 17 (03) : 225 - 229
  • [7] Beneficial effects of nateglinide on insulin resistance in type 2 diabetes
    Hazama, Y
    Matsuhisa, M
    Ohtoshi, K
    Gorogawa, S
    Kato, K
    Kawamori, D
    Yoshiuchi, K
    Nakamura, Y
    Shiraiwa, T
    Kaneto, H
    Yamasaki, Y
    Hori, M
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2006, 71 (03) : 251 - 255
  • [8] Effects of metformin and troglitazone on insulin secretion and hepatic insulin extraction in type-2 diabetes
    Kautzky-Willer, A
    Ludvik, B
    Prager, R
    Pacini, G
    DIABETES, 1999, 48 : A352 - A352
  • [9] Comparison of effects of repaglinide and nateglinide on insulin secretion and postloading glucose excursions in patients with type 2 diabetes
    Rudovich, N
    Rochlitz, H
    Dieken, ML
    Pfeiffer, A
    DIABETES, 2003, 52 : A454 - A454
  • [10] Insulin-sensitizing effects of nateglinide on type 2 diabetes mellitus
    Nishimura, H
    Aotani, D
    Nakano, A
    Shintani, MS
    Maeda, K
    DIABETES, 2004, 53 : A484 - A484